P254 Effect of standard treatment (ST) versus episodic (ET) or maintenance (MT) infliximab on healthcare cost (HC) and quality-adjusted life years (QALYs) in a community-based incidence cohort of adult Crohn's disease patients with 10 years follow-up

Authors :: Ebbe Langholz
Bjørn Moum
Shmuel Odes
Pia S. Munkholm
Colm O'Morain
Hillel Vardi
Reinhold W. Stockbrügger
Dan Greenberg
Michael Friger
Source :: Journal of Crohn's and Colitis. 6:S110-S111
Publication Year :: 2012
Publisher :: Oxford University Press (OUP), 2012.

Subjects :: Community based
Crohn's disease
Pediatrics
medicine.medical_specialty
business.industry
Incidence (epidemiology)
Standard treatment
Gastroenterology
General Medicine
medicine.disease
Infliximab
Quality-adjusted life year
Cohort
medicine
Healthcare cost
business
medicine.drug

Full Text Access

Tools